Alex Shved is fighting his Stage 4 cancer on two fronts. Medication he is receiving as part of an early-stage trial is working with his body, he hopes, to attack melanoma that has metastasized. At the same time, he is taking up arms against another formidable foe: the health-care bureaucracy. Shved, 37, has tried various […]